166 related articles for article (PubMed ID: 35928681)
1. TGF-β1-Mediated Leukocyte Cell-Derived Chemotaxin 2 Is Associated With Liver Fibrosis in Biliary Atresia.
Zhao J; Xu X; Gou Q; Zheng Q; Ge L; Chen L; Zhang C; Ma H; Lin S; Hu X; Zhan J
Front Pediatr; 2022; 10():901888. PubMed ID: 35928681
[TBL] [Abstract][Full Text] [Related]
2. Identifying Biomarkers to Predict the Prognosis of Biliary Atresia by Weighted Gene Co-Expression Network Analysis.
Kong M; Xiang B
Front Genet; 2021; 12():760182. PubMed ID: 34899846
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Interleukin-33/ST2 Receptor and Liver Fibrosis Progression in Biliary Atresia Patients.
Liu J; Yang Y; Zheng C; Chen G; Shen Z; Zheng S; Dong R
Front Pediatr; 2019; 7():403. PubMed ID: 31632941
[No Abstract] [Full Text] [Related]
4. LECT2, A Novel and Direct Biomarker of Liver Fibrosis in Patients With CHB.
Xu H; Li X; Wu Z; Zhao L; Shen J; Liu J; Qin J; Shen Y; Ke J; Wei Y; Li J; Gao Y
Front Mol Biosci; 2021; 8():749648. PubMed ID: 34631799
[TBL] [Abstract][Full Text] [Related]
5. Abnormal activation of OPN inflammation pathway in livers of children with biliary atresia and relationship to hepatic fibrosis.
Huang L; Wei MF; Feng JX
Eur J Pediatr Surg; 2008 Aug; 18(4):224-9. PubMed ID: 18704890
[TBL] [Abstract][Full Text] [Related]
6. Necroptosis of macrophage is a key pathological feature in biliary atresia via GDCA/S1PR2/ZBP1/p-MLKL axis.
Yang S; Chang N; Li W; Yang T; Xue R; Liu J; Zhang L; Yao X; Chen Y; Wang H; Yang L; Huang J; Li L
Cell Death Dis; 2023 Mar; 14(3):175. PubMed ID: 36859525
[TBL] [Abstract][Full Text] [Related]
7. Expression of transforming growth factor-β1 and connective tissue growth factor in congenital biliary atresia and neonatal hepatitis liver tissue.
Li FB; Zhao H; Peng KR; Gao ZG; Huang SJ; Tou JF; Shu XL; Gu WZ
Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909983
[TBL] [Abstract][Full Text] [Related]
8. Global research trends and hotspots for leukocyte cell-derived chemotaxin-2 from the past to 2023: a combined bibliometric review.
Liu W; Wang Q; Yeerlan J; Yan Y; Xu L; Jia C; Liu X; Zhang L
Front Immunol; 2024; 15():1413466. PubMed ID: 38881894
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of leukocyte cell-derived chemotaxin 2 are associated with the prevalence of metabolic syndrome.
Zheng X; Lu J; Xiang S; Zou P; Chen H; Liu J; Zeng C; He Y
Acta Diabetol; 2024 May; 61(5):643-655. PubMed ID: 38383671
[TBL] [Abstract][Full Text] [Related]
10. Serum transforming growth factor-beta1 and epidermal growth factor in biliary atresia.
Vejchapipat P; Theamboonlers A; Poomsawat S; Chittmittrapap S; Poovorawan Y
Eur J Pediatr Surg; 2008 Dec; 18(6):415-8. PubMed ID: 19012231
[TBL] [Abstract][Full Text] [Related]
11. Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liver.
Okumura A; Unoki-Kubota H; Matsushita Y; Shiga T; Moriyoshi Y; Yamagoe S; Kaburagi Y
Biosci Trends; 2013 Dec; 7(6):276-83. PubMed ID: 24390366
[TBL] [Abstract][Full Text] [Related]
12. Increased MMP-7 expression in biliary epithelium and serum underpins native liver fibrosis after successful portoenterostomy in biliary atresia.
Kerola A; Lampela H; Lohi J; Heikkilä P; Mutanen A; Hagström J; Tervahartiala T; Sorsa T; Haglund C; Jalanko H; Pakarinen MP
J Pathol Clin Res; 2016 Jul; 2(3):187-98. PubMed ID: 27499927
[TBL] [Abstract][Full Text] [Related]
13. Infiltration of polarized macrophages associated with liver fibrosis in infants with biliary atresia.
Yang Y; Dong R; Zheng C; Zheng S; Chen G
J Pediatr Surg; 2017 Dec; 52(12):1984-1988. PubMed ID: 28927974
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte cell-derived chemotaxin 2 promotes the development of nonalcoholic fatty liver disease through STAT-1 pathway in mice.
Wang J; Chen Y; Pan R; Wu C; Chen S; Li L; Li Y; Yu C; Meng ZX; Xu C
Liver Int; 2021 Apr; 41(4):777-787. PubMed ID: 33555112
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-Weighted Imaging for Differentiation of Biliary Atresia and Grading of Hepatic Fibrosis in Infants with Cholestasis.
Kim J; Shin HJ; Yoon H; Han SJ; Koh H; Kim MJ; Lee MJ
Korean J Radiol; 2021 Feb; 22(2):253-262. PubMed ID: 32901459
[TBL] [Abstract][Full Text] [Related]
16. Serum TGF-
Chang D; Geng X; Zhou L; Hou G
Comput Math Methods Med; 2022; 2022():5802548. PubMed ID: 35912145
[TBL] [Abstract][Full Text] [Related]
17. Elucidation of pericholangitis and periductal fibrosis in cholestatic liver diseases via extracellular vesicles released by polarized biliary epithelial cells.
Maki K; Katsumi T; Hanatani T; Uchiyama F; Suzuki F; Hoshikawa K; Haga H; Saito T; Ueno Y
Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1094-C1105. PubMed ID: 38344767
[TBL] [Abstract][Full Text] [Related]
18. Association between Leukocyte Cell-Derived Chemotaxin 2 and Metabolic and Renal Diseases in a Geriatric Population: A Pilot Study.
Kuzan A; Maksymowicz K; Królewicz E; Lindner-Pawłowicz K; Zatyka P; Wojnicz P; Nowaczyński M; Słomczyński A; Sobieszczańska M
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137613
[TBL] [Abstract][Full Text] [Related]
19. Serum leukocyte cell-derived chemotaxin 2 level is associated with atopic dermatitis patients.
Zhao K; Xu F; Jiang X; Chen J; Zhu X; Zhou Q; Xu S
Ann Palliat Med; 2021 Oct; 10(10):11006-11012. PubMed ID: 34763463
[TBL] [Abstract][Full Text] [Related]
20. Role of leukocyte cell-derived chemotaxin 2 as a biomarker in hepatocellular carcinoma.
Okabe H; Delgado E; Lee JM; Yang J; Kinoshita H; Hayashi H; Tsung A; Behari J; Beppu T; Baba H; Monga SP
PLoS One; 2014; 9(6):e98817. PubMed ID: 24892551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
